Home
NewsNewsCostco, Sesame, and IVI RMA North America have announced strategic partnership to alter fertility care in the U.S. by removing biggest obstacles to care including high costs and limited access.
On March 09, 2026, Costco, Sesame, and IVI RMA North America, the three leaders, went ahead and announced a strategic partnership to change how people get fertility care in the U.S. and remove the biggest obstacles to care for every 1 in 6 Americans who are infertile and want to start a family. The partnership makes it pretty easy for people to get high-quality fertility care in the U.S. along with advanced reproductive medicine specialists. It also offers affordable and competitive prices in addition to coordinated care throughout the fertility journey.
As per Senior Vice President of Pharmacy at Costco, Richard Stephens, "Our partnership with Sesame and IVI RMA reflects our commitment to transparent and affordable solutions that reduce barriers and are more accessible and more affordable for our members. By combining transparent pricing with coordinated care, we're removing the barriers that have historically kept quality fertility treatment out of reach for too many families."
Costco members who sign up for a monthly membership get immediate access to Sesame fertility care coordination, full diagnostic workups, and a clear path to speciality treatment. Every patient starts with Sesame and gets a full intake assessment, coordinated diagnostic support, and a referral to highly experienced speciality care with IVI RMA North America when it is clinically suitable. Patients come to IVI RMA North America clinics ready to focus on customised fertility planning and treatment because they are well-informed and prepared.
Costco provides medication for fertility drugs and offers exclusive member pricing, which can save you up to 80% on drugs like Follistim through pharmacy programmes. This cuts down on one of the biggest out-of-pocket costs for fertility care by a huge amount, saving patients thousands of dollars on each cycle.
If speciality care is needed, patients are sent directly to IVI RMA, where Costco members can get even more discounts. IVI RMA offers high-acuity speciality care like IVF and IUI through its state-of-the-art clinics, which have the highest success rates in the industry. During the process of the treatment, patients keep their Sesame clinician as a dedicated partner when it comes to medical advice, including translating medical terms, offering emotional support, and also coordinating care. This ensures continuity of care and clarity, along with a high level of personalised attention.
Says David Goldhill, CEO & Founder of Sesame, "This partnership empowers people to take control of their reproductive health without barriers, stigma, or waiting. By connecting patients directly with care coordinators and world-class specialists, we're making family planning accessible and delivering measurably better outcomes through coordinated, continuous care."
According to CEO of IVI RMA North America, Lynn Mason, “The presidential order was a clear call to action and as leaders of the fertility industry, we are executing on that mandate. In partnership with Costco and Sesame, leaders of the highest calibre, we are expanding access to quality fertility care and reducing barriers so more people across the country can build the families they desire. Every partnership we form and programme we launch is grounded in expanding access to the most advanced care for individuals and families who deserve expertise and support throughout their fertility journey.”
The partnership will make it much easier for families looking for fertility care in the U.S. to get treatment, find the right tests, and save money on healthcare costs by integrating Sesame's direct-access platform with IVI RMA Network's clinical expertise and Costco's clear pricing.
A groundbreaking Nature Medicine study compares AI deep learning against expert embryologists in selecting embryos. While pregnancy rates remain comparable, the study uncovers a massive advantage in efficiency that could revolutionize IVF labs worldwide. Discover how AI-driven embryo selection accuracy is reshaping the future of fertility treatment.
FertilAI has received EU MDR clearance for tools advancing Predictive AI in Fertility through its Fertilane platform. StimAI and OvuPredict help clinicians optimise IVF timing, predict ovulation and improve scheduling efficiency. The technology supports scalable fertility care, reduced monitoring needs and better patient treatment experiences globally.
The Ferring Global Fertility Monitor has been launched by Ferring Pharmaceuticals and Gallup to examine fertility trends in 70 countries. Through large-scale surveys, the project will explore economic, social, and cultural influences on parenthood decisions. Insights are expected to guide policy, healthcare planning, and future demographic strategies.
Maven Clinic has expanded its Fertility and Family Building program with earlier diagnostics, wearable integration, and AI-powered personalised care. The enhanced platform supports faster diagnosis, improved treatment decisions, and condition-specific pathways for PCOS, endometriosis, and oncofertility. The rollout continues through 2026 with added innovations and partnerships.
Germany is debating the legalization of egg donation in Germany, challenging decades-old restrictions under the Embryo Protection Act. Experts argue reform is overdue to align with modern reproductive science, reduce fertility tourism, and improve patient care, while policymakers work to balance ethical concerns with growing demand for advanced fertility treatments.
A new review highlights the link from Forever Chemicals to reduced ART outcomes, showing how PFAS exposure impacts fertility, pregnancy, and reproductive health. The findings raise urgent concerns for IVF patients and call for stronger regulation, deeper research, and systemic action to address environmental risks in reproductive medicine.
The 2027 Title X NOFO introduces a major policy shift toward addressing infertility crisis in the U.S. It mandates basic infertility services, expands male reproductive health focus, and promotes education on body literacy and lifestyle factors, aiming to support family formation alongside traditional contraceptive services.
